[india-drug] Expert committee on selection and use of essential medicines

[Dr.Hogerzeil.hogerzeilh@who.int]

Expert committee on selection and use of essential medicines
 ----------------------------------------------------------            
        
Dear all,


Due to a mixture of staff overload, need for more time to prepare
reviews and uncertainty about the availability of the necessary funds
from WHO's budget, it has been decided to reschedule the next meeting
of the Expert Committee on the Selection and Use of Essential Medicines
to Spring 2005, with 7-11 March 2005 as the provisional dates. 

The closing date for applications for inclusion, change or deletion of
medicines is now 31 October 2004. However, it is recommended that
applications be submitted as soon as possible to allow good time for
external review. More information on the meeting can be found at the
web site
                     
http://www.who.int/medicines/organization/par/edl/expcom14/expertcomm14.shtml.

In general it has been decided to go back to two-yearly updates of the
Model
List, followed by similar two-yearly updates of the WHO Model
Formulary. So,
the 2003 Model List will now be followed by the 2004 Model Formulary
(due to
be issued in January 2004); the 2005 Model List will be followed by the
2006
Model Formulary, etc.

I would also like to remind you that both the Model List, the Model
Formulary and all necessary links to WHO clinical guidelines, evidence,
prices and normative information can be found at the new WHO Essential
Medicines Library at
http://mednet3.who.int/eml/.

With best regards,

Hans V. Hogerzeil, MD, PhD, FRCP Edin
Coordinator for policy, access and rational use
Department of Essential Drugs and Medicines Policy
World Health Organisation, 1211 Geneva
Tel +41-22-7913528
Fax +41-22-7914167
<hogerzeilh@who.int>


________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org